Unicycive Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Unicycive Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.05 USD/shares, a 61.5% increase year-over-year.
  • Unicycive Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.47 USD/shares, a 73% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.28 USD/shares, a 6.67% decline from 2022.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.2 USD/shares, a 39.5% decline from 2021.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.86 USD/shares, a 219% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 $0 -6.67% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$1 $0 -39.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$1 -$1 -219% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.